ES2150414T3 - El uso de promotores autologos para expresar productos genicos en bordetella. - Google Patents

El uso de promotores autologos para expresar productos genicos en bordetella.

Info

Publication number
ES2150414T3
ES2150414T3 ES91303320T ES91303320T ES2150414T3 ES 2150414 T3 ES2150414 T3 ES 2150414T3 ES 91303320 T ES91303320 T ES 91303320T ES 91303320 T ES91303320 T ES 91303320T ES 2150414 T3 ES2150414 T3 ES 2150414T3
Authority
ES
Spain
Prior art keywords
gene
autologous
products
bordetella
promoters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91303320T
Other languages
English (en)
Inventor
Sheena Loosmore
Gavin Zealey
Reza Khayyam Yacoob
Michel Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Connaught Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Laboratories Ltd filed Critical Connaught Laboratories Ltd
Application granted granted Critical
Publication of ES2150414T3 publication Critical patent/ES2150414T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROMOTORES AUTOLOGOS SE UTILIZAN PARA PRODUCIR LA EXPRESION DE PRODUCTOS DE GENES EN CADENAS DE PERTISIS. LOS GENES DE PERTISIS HIBRIDOS ESTAN FORMADOS DE UN GEN DE PERTUSIS ESTRUCTURAL FUSIONADO A UN CODON ATG A UNO NATIVO PERO PROMOTOR DE PERTUSIS AUTOLOGO. LA B PERTUSSIS, TRANSFORMADA POR EL GEN HIBRIDO MEDIANTE LA INTRODUCCION EN EL CROMOSOMA DEL ORGANISMO POR RECOMBINACION HOMOLOGA EN LUGARES ESPECIFICOS, PRODUCE LA EXPRESION DE LA PROTEINA ANTIGENICA PARA LA CUAL EL GEN ESTRUCTURAL CODIFICA A UNA VELOCIDAD DE PRODUCCION DIFERENTE DE LA ALCANZADA POR EL GEN HOMOLOGO. SE DESCRIBEN CADENAS ESPECIFICAS Y PLASMIDAS. LA TECNICA ES APLICABLE A UNA GRAN VARIEDAD DE PRODUCTOS DE GENES Y ORGANISMOS.
ES91303320T 1990-04-18 1991-04-16 El uso de promotores autologos para expresar productos genicos en bordetella. Expired - Lifetime ES2150414T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909008746A GB9008746D0 (en) 1990-04-18 1990-04-18 The use of autologous promoters to express gene products in bordetella

Publications (1)

Publication Number Publication Date
ES2150414T3 true ES2150414T3 (es) 2000-12-01

Family

ID=10674630

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91303320T Expired - Lifetime ES2150414T3 (es) 1990-04-18 1991-04-16 El uso de promotores autologos para expresar productos genicos en bordetella.

Country Status (9)

Country Link
EP (1) EP0453216B1 (es)
JP (1) JP3004414B2 (es)
AT (1) ATE195143T1 (es)
CA (1) CA2040548C (es)
DE (1) DE69132342T2 (es)
DK (1) DK0453216T3 (es)
ES (1) ES2150414T3 (es)
GB (1) GB9008746D0 (es)
GR (1) GR3034693T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9115332D0 (en) * 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
FR2718750B1 (fr) * 1994-04-19 1996-06-14 Pasteur Institut Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants.
US5932714A (en) * 1995-02-23 1999-08-03 Connaught Laboratories Limited Expression of gene products from genetically manipulated strains of Bordetella
US5998168A (en) * 1995-06-07 1999-12-07 Connaught Laboratories Limited Expression of gene products from genetically manipulated strains of bordetella
FR2768747B1 (fr) 1997-09-19 2000-12-01 Pasteur Institut Acides nucleiques, cellules recombinantes, et procede de preparation de compositions immunogenes
AU2002301780B2 (en) * 1997-09-19 2007-02-08 Institut Pasteur Clostridium toxin and method for preparing immunogenic compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
IT1224254B (it) * 1988-04-08 1990-09-26 Sclavo Spa Sistema di regolazione positivo inducibile utile per la produzione di proteine eterologhe
US5000952A (en) * 1988-08-02 1991-03-19 The Board Of Trustees Of The Leland Stanford, Jr. University Polypeptide pertussis toxin vaccine
CA1341123C (en) * 1988-10-27 2000-10-17 David A. Relman Filamentous hemagglutinin of b. pertussis
IT1236971B (it) * 1989-11-03 1993-05-07 Eniricerche Spa Regione promotore dei geni codificanti le subunita' piliniche fim2, fm3 e fimx di bordetella pertussis e loro impiego per l'espressione di geni che codificano una proteina di interesse.
DE779362T1 (de) * 1989-12-22 2001-04-05 Applied Research Systems Ars Holding N.V., Curacao DNS-Konstrukten zur Aktivierung und Veränderung der Expression von endogenen Genen

Also Published As

Publication number Publication date
DE69132342T2 (de) 2001-02-15
CA2040548C (en) 1998-06-30
CA2040548A1 (en) 1991-10-19
GR3034693T3 (en) 2001-01-31
ATE195143T1 (de) 2000-08-15
DK0453216T3 (da) 2000-09-04
EP0453216A3 (en) 1992-04-22
JPH0568556A (ja) 1993-03-23
EP0453216B1 (en) 2000-08-02
JP3004414B2 (ja) 2000-01-31
DE69132342D1 (de) 2000-09-07
GB9008746D0 (en) 1990-06-13
EP0453216A2 (en) 1991-10-23

Similar Documents

Publication Publication Date Title
ES8505412A1 (es) Un metodo para producir eficazmente un factor de crecimiento similar a insulina humana
BR1100650A (pt) Proteìnas de superfìcie cd44 variantes, sequências de dna que as codificam, anticorpos contra estas proteìnas, bem como a sua utilização no diagnóstico e na terapia
ATE92959T1 (de) Herstellung von chimaeren antikoerpern.
ES2072900T3 (es) Expresion elevada de proteinas en levadura.
DK371087D0 (da) Mamalialt interleukin-4
ATE123065T1 (de) Proteine und deren herstellung.
EP0692031A4 (en) HETEROLOGIST ANTIGENES IN STRAINS FOR VACCINATION WITH LIVING CELLS
DE69521752D1 (de) Verfahren für die Herstellung von Proteinen
NO175871C (no) Gjærhybridpromotor, gjærhybridvektor, Saccharomyces spec.-vert, samt fremgangsmåte for fremstilling av et polypeptid heterologt med gjær
ATE173023T1 (de) Dna-sequenzen kodierend für das polypeptid gelonin
ATE125815T1 (de) Expressionsvektor für hefe.
DE59611434D1 (de) Herstellung von Proteinen aus Pro-Proteinen durch Fusionsproteine abgeleitet von Furin oder Furinanalogen
ES8500327A1 (es) Procedimiento para producir polipeptido
ES2053631T3 (es) Purificacion del factor viii:c por afinidad con fosfolipidos.
DK0453216T3 (da) Anvendelse af autologe promotorer til ekspression af genprodukter i Bordetella
SE8605621D0 (sv) Heteromultimeric proteins and their manufacture
ES8800722A1 (es) Metodo de produccion de un factor liberador de la hormona del crecimiento por la expresion en e. coli de polipeptidos hibridos
KR880001813A (ko) 인슈린 양성자인자의 제조방법 및 그 제조를 위한 프라즈미드의 제조방법
ATE105864T1 (de) Rekombinante plasmide, die zur expression von heterologen proteinen in bacillus verwendet werden können.
ES2091179T3 (es) Fragmentos de adn de replicacion autonoma, derivados de celulas de mamiferos y que tienen una afinidad respecto a las proteinas que se fijan en el adn.
DE3876294D1 (de) Verfahren zur herstellung von substituierten lactamen.
ATE178655T1 (de) Herstellungsprozess von fremdprotein
RO96363B1 (ro) Procedeu de preparare a antigenului de suprafata al hepatitei b

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 453216

Country of ref document: ES